Raymond James Financial
ALT icon

Raymond James Financial’s Altimmune ALT Stock Holding History

Raymond James Financial’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$166K Sell
53,796
-2,063
-4% -$8.76K ﹤0.01% 4926
2025
Q4 		$202K Buy
55,859
+28,187
+102% +$123K ﹤0.01% 4789
2025
Q3 		$104K Buy
27,672
+1,703
+7% +$6.58K ﹤0.01% 4743
2025
Q2 		$101K Buy
25,969
+11,309
+77% +$61.2K ﹤0.01% 4871
2025
Q1 		$73.3K Buy
14,660
+2,420
+20% +$15.3K ﹤0.01% 4598
2024
Q4 		$88.3K Buy
+12,240
New +$93.5K ﹤0.01% 4543

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Raymond James Financial's ALT Position: Q1 2026 in Review

Raymond James Financial reduced its Altimmune (ALT) stake by 3.7% in Q1 2026, selling an estimated $8.76K and leaving 53,796 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #4926.

Raymond James Financial first reported a position in ALT in Q4 2024 and has held it in 6 quarters since. The position peaked at $202K in Q4 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Raymond James Financial held 53,796 shares of Altimmune worth $166K as of Q1 2026.
  • Raymond James Financial sold 2,063 Altimmune shares in Q1 2026, an estimated $8.76K.
  • Altimmune made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4926 holding.
  • Raymond James Financial first reported a position in Altimmune in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Altimmune position peaked at $202K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.